Patents by Inventor Martin Packer

Martin Packer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL COMPOUNDS
    Publication number: 20240010631
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 11, 2024
    Inventors: JEFFREY WALLACE JOHANNES, SUDHIR MAHADEO HANDE, AVIPSA GHOSH, XIAOLAN ZHENG, MARTIN PACKER, SEBASTIEN LOUIS DEGORCE
  • Chemical compounds
    Patent number: 11795158
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: October 24, 2023
    Assignee: ASTRAZENECA AB
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Avipsa Ghosh, Xiaolan Zheng, Martin Packer, Sebastien Louis Degorce
  • CHEMICAL COMPOUNDS
    Publication number: 20220009901
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: June 22, 2021
    Publication date: January 13, 2022
    Inventors: JEFFREY WALLACE JOHANNES, SUDHIR MAHADEO HANDE, AVIPSA GHOSH, XIAOLAN ZHENG, MARTIN PACKER, SEBASTIEN LOUIS DEGORCE
  • C-anilinoquinazoline compounds and their use in treating cancer
    Patent number: 10829479
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: November 10, 2020
    Assignee: AstraZeneca AB
    Inventors: Jason Kettle, Stuart Pearson, Martin Packer, James Smith, Tudor Grecu
  • C5-anilinoquinazoline Compounds and Their Use in Treating Cancer
    Publication number: 20190263787
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Application
    Filed: March 5, 2019
    Publication date: August 29, 2019
    Inventors: Jason Kettle, Stuart Pearson, Martin Packer, James Smith, Tudor Grecu
  • C5-anilinoquinazoline compounds and their use in treating cancer
    Patent number: 10273227
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: April 30, 2019
    Assignee: AstraZeneca AB
    Inventors: Jason Kettle, Stuart Pearson, Martin Packer, James Smith
  • C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
    Publication number: 20180312490
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Application
    Filed: April 26, 2018
    Publication date: November 1, 2018
    Inventors: Jason KETTLE, Stuart Pearson, Martin Packer, James Smith, Tudor Grecu
  • Chemical compounds
    Patent number: 8673938
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: March 18, 2014
    Assignee: AstraZeneca AB
    Inventors: William McCoull, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore
  • Chemical compounds
    Patent number: 7964618
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 21, 2011
    Assignee: AstraZeneca AB
    Inventors: William McCoull, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore
  • 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic Acid - 465
    Publication number: 20110060022
    Abstract: 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid and pharmaceutically-acceptable salts thereof and a particular crystalline form of the Agent (Form 1); their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: November 5, 2008
    Publication date: March 10, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Martin Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore
  • PYRIDINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE FOR INHIBITING 11-BETA-HYDROXYSTEROID DEHYDROGENASE
    Publication number: 20100022589
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Application
    Filed: July 26, 2007
    Publication date: January 28, 2010
    Inventors: William McCoull, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore
  • CHEMICAL COMPOUNDS
    Publication number: 20090312372
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Application
    Filed: August 14, 2009
    Publication date: December 17, 2009
    Applicant: AstraZeneca AB
    Inventors: William MCCOULL, Martin PACKER, James Stewart SCOTT, Paul Robert Owen WHITTAMORE
  • CHEMICAL COMPOUNDS
    Publication number: 20090306075
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Application
    Filed: August 14, 2009
    Publication date: December 10, 2009
    Applicant: AstraZeneca AB
    Inventors: William MCCOULL, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore
  • SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281
    Publication number: 20090264401
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: April 21, 2009
    Publication date: October 22, 2009
    Applicant: AstraZeneca AB
    Inventors: Adrian Liam GILL, Andrew Leach, Martin Packer, James Stewart Scott, Pernilla Sorme, John Gibbin Swales, Paul Robert Owen Whittamore
  • CHEMICAL COMPOUNDS
    Publication number: 20080269288
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Application
    Filed: October 30, 2007
    Publication date: October 30, 2008
    Applicant: AstraZeneca AB
    Inventors: William McCoull, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore